In recent years, the newer drugs, which account for about 90 percent of the market, have become increasingly controversial, as prescription rates to children and
elderly people have soared. Doctors
use the drugs to settle outbursts related to a host of psychiatric disorders, including attention deficit disorder and Alzheimer’s disease. Most are not approved for such use.